Paris B. Adkins-Jackson, PhD, MPH, Rupinder K. Legha, MD, and Kyle A. Jones, RN
Institutional racism mediates structural racism and is embedded in institutional policies, clinical practice, health professional training, and biomedical research.
AMA J Ethics. 2021;23(2):E140-145. doi:
10.1001/amajethics.2021.140.
Zahra H. Khan, MS, Yoshiko Iwai, MS, and Sayantani DasGupta, MD, MPH
In 2020, the authors of this article published “Abolition Medicine” as one contribution to international abolitionist conversations responding to widespread anti-Black police violence and inequity laid bare by the COVID-19 pandemic.
AMA J Ethics. 2022;24(3):E239-246. doi:
10.1001/amajethics.2022.239.
Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.
AMA J Ethics. 2020;22(8):E743-750. doi:
10.1001/amajethics.2020.743.
Where people live and work influences how long and how well they live. Supporting community investments can diminish risk, improve outcomes, and reduce costs.
AMA J Ethics. 2019;21(3):E262-268. doi:
10.1001/amajethics.2019.262.
Should old folks who have lived their lives be allowed to place a huge economic burden on the young by using a disproportionate amount of limited Medicare resources for medical care?